Close
Back to AMRN Stock Lookup

Amarin Corp. (AMRN) –

Aug 15, 2022 08:01 AM Amarin Corp. (AMRN) Announces Latest Research Evaluating VASCEPA/VAZKEPA and Subgroups from REDUCE-IT Landmark Outcomes Trial to be Presented at ESC Congress
Aug 15, 2022 08:00 AM Latest Research Evaluating VASCEPA®/VAZKEPA (icosapent ethyl) and Subgroups from the REDUCE-IT® Landmark Outcomes Trial to be Presented at the European Society of Cardiology (ESC) Congress
Aug 15, 2022 08:00 AM Latest Research Evaluating VASCEPA®/VAZKEPA (icosapent ethyl) and Subgroups from the REDUCE-IT® Landmark Outcomes Trial to be Presented at the European Society of Cardiology (ESC) Congress
Aug 5, 2022 05:17 PM Form S-8 AMARIN CORP PLC\UK
Aug 3, 2022 07:13 AM Form 10-Q AMARIN CORP PLC\UK For: Jun 30
Aug 3, 2022 07:09 AM Form 8-K AMARIN CORP PLC\UK For: Aug 03
Aug 3, 2022 07:06 AM Amarin Corp. (AMRN) Misses Q2 EPS by 3c
Aug 3, 2022 07:00 AM Amarin Reports Second Quarter 2022 Financial Results and Provides Business Update
Aug 3, 2022 07:00 AM Amarin Reports Second Quarter 2022 Financial Results and Provides Business Update
Aug 2, 2022 08:08 PM Form 4 AMARIN CORP PLC\UK For: Jul 29 Filed by: Kalb Michael Wayne
Aug 2, 2022 08:08 PM Form 4 AMARIN CORP PLC\UK For: Jul 29 Filed by: Berg Aaron
Aug 2, 2022 08:08 PM Form 4 AMARIN CORP PLC\UK For: Jul 29 Filed by: Ketchum Steven B
Aug 1, 2022 05:04 PM JPMorgan Assumes Amarin Corporation (AMRN) at Underweight
Jul 26, 2022 04:35 PM Scholar Rock (SRRK) Announces the Addition of Srinivas Akkaraju, M.D., Ph.D. to Its Board of Directors
Jul 26, 2022 04:30 PM Scholar Rock Announces the Addition of Srinivas Akkaraju, M.D., Ph.D. to Its Board of Directors
Jul 20, 2022 08:00 AM Amarin to Report Second Quarter 2022 Financial Results and Host Conference Call on August 3, 2022
Jul 20, 2022 08:00 AM Amarin to Report Second Quarter 2022 Financial Results and Host Conference Call on August 3, 2022
Jul 13, 2022 08:00 AM Amarin (AMRN) Announces NICE Issues Final Guidance for Reimbursement Making VAZKEPA
Jul 13, 2022 08:00 AM NICE Issues Final Guidance for Reimbursement Making VAZKEPA® (icosapent ethyl) Available Across the NHS in England & Wales
Jul 13, 2022 08:00 AM NICE Issues Final Guidance for Reimbursement Making VAZKEPA® (icosapent ethyl) Available Across the NHS in England & Wales
Jul 6, 2022 08:13 PM Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Mikhail Karim
Jul 6, 2022 08:11 PM Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Reilly Thomas Charles
Jul 6, 2022 08:10 PM Form 3 AMARIN CORP PLC\UK For: Jun 30 Filed by: Reilly Thomas Charles
Jun 30, 2022 05:21 PM Form 8-K AMARIN CORP PLC\UK For: Jun 27
Jun 30, 2022 04:06 PM Amarin Corp. (AMRN) Announces REDUCE-IT Exploratory Post Hoc Biomarker Sub-Analysis Shows Relatively Small Changes in Inflammatory Markers Between Icosapent Ethyl and Placebo
Jun 30, 2022 04:05 PM REDUCE-IT Exploratory Post Hoc Biomarker Sub-Analysis Shows Relatively Small Changes in Inflammatory Markers Between Icosapent Ethyl and Placebo
Jun 30, 2022 04:05 PM REDUCE-IT Exploratory Post Hoc Biomarker Sub-Analysis Shows Relatively Small Changes in Inflammatory Markers Between Icosapent Ethyl and Placebo
Jun 30, 2022 01:17 PM Amarin Corp. (AMRN) Lower Following STAT Report
Jun 29, 2022 08:09 PM Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: Zulueta Alfonso G
Jun 29, 2022 08:08 PM Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: ENRIGHT ERIN S.
Jun 29, 2022 08:08 PM Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: VAN HEEK G JAN
Jun 29, 2022 08:07 PM Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: Peterson Kristine
Jun 29, 2022 08:06 PM Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: O'Sullivan Patrick J
Jun 29, 2022 08:05 PM Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: Ekman Lars
Jun 29, 2022 08:04 PM Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: WOLD OLSEN PER
Jun 22, 2022 05:44 PM Greater Competition Does Not Impact Investment Thesis - Cantor Fitzgerald Reiterates Amarin Corporation (AMRN)at Overweight
Jun 17, 2022 04:52 PM Form DEFA14A AMARIN CORP PLC\UK
Jun 16, 2022 06:05 AM Form SC 13D/A AMARIN CORP PLC\UK Filed by: Sarissa Capital Management LP
Jun 15, 2022 08:02 PM Form 4 AMARIN CORP PLC\UK For: Jun 13 Filed by: WOLD OLSEN PER
Jun 15, 2022 04:50 PM Sarissa Capital Intends to Vote “Abstain” at the Amarin Annual Meeting
Jun 10, 2022 06:00 AM Amarin Corp. (AMRN) Announces Positive Recommendation from UK's NICE for Reimbursement of VAZKEPA
Jun 10, 2022 06:00 AM Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)
Jun 10, 2022 06:00 AM Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)
Jun 6, 2022 04:36 PM Form 8-K AMARIN CORP PLC\UK For: Jun 01
Jun 6, 2022 12:12 PM JPMorgan on Underweight-rated Amarin Corporation (AMRN), 'we see a difficult path ahead for the stock'
Jun 6, 2022 09:34 AM Amarin to slash jobs as generic rivals dull U.S. prospects of heart drug
Jun 6, 2022 08:33 AM Amarin Corp. (AMRN) Announces Comprehensive Cost Reduction Plan
Jun 6, 2022 08:30 AM Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business
Jun 6, 2022 08:30 AM Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business
Jun 6, 2022 08:16 AM Amarin Corp. (AMRN) Appoints Tom Reilly as New Chief Financial Officer

Back to AMRN Stock Lookup